Related Experiment Video
Updated: Jun 7, 2025

09:58
Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models
Published on: December 9, 2016
13.6K
OncoSplicing 3.0: an updated database for identifying RBPs regulating alternative splicing events in cancers
Yangjun Zhang1,2,3,4, Kai Liu3, Zhenzhen Xu3
1Cancer Precision Diagnosis and Treatment and Translational Medicine Hubei Engineering Research Center, Zhongnan Hospital, Wuhan University, Wuhan 430000, China.
Nucleic Acids Research
|November 18, 2024
Summary
The updated OncoSplicing database helps identify RNA-binding proteins (RBPs) that regulate alternative splicing (AS) in cancer. This resource aids researchers in understanding cancer-specific AS events and validating potential RBP targets.
Area of Science:
- Molecular Biology
- Genomics
- Bioinformatics
Background:
- Alternative splicing (AS) is a key regulator of gene expression and protein diversity.
- RNA-binding proteins (RBPs) are implicated in aberrant AS in cancer, but resources for identifying specific RBPs are limited.
- The OncoSplicing database was initially developed for analyzing TCGA cancer splicing events.
Purpose of the Study:
- To enhance the OncoSplicing database as a comprehensive resource for identifying RBPs regulating specific AS events in cancer.
- To provide tools for experimental validation of AS events and their regulatory RBPs.
Main Methods:
- Integrated TCGA and GTEx splicing and mRNA expression data.
- Mapped RNA-binding motifs and eCLIP-seq peaks to AS events.
- Analyzed RNA-seq data from RBP perturbation experiments (ENCODE).
- Incorporated exon and intron sequences for each AS event.
Main Results:
- The updated OncoSplicing database links AS events to potential regulatory RBPs.
- Users can identify candidate RBPs for specific AS events.
- Sequences for designing validation constructs (primers, minigenes) are available.
Conclusions:
- The substantially updated OncoSplicing database (www.oncosplicing.com) is a valuable resource for cancer research.
- Facilitates the identification of RBPs driving cancer-specific alternative splicing.
- Supports experimental validation of AS regulatory mechanisms in cancer.
Related Concept Videos
Alternative RNA Splicing
21.0K
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
21.0K
RNA Splicing
56.0K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
56.0K

